Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-12-040678
Filing Date
2012-07-24
Accepted
2012-07-24 12:25:22
Documents
1
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 v319345_10ka1.htm 10-K/A 28629
  Complete submission text file 0001144204-12-040678.txt   29833
Mailing Address 125 MAIDEN LANE, SUITE 309 NEW YORK NY 10038
Business Address 125 MAIDEN LANE, SUITE 309 NEW YORK NY 10038 212-797-9877
Tongli Pharmaceuticals (USA), Inc. (Filer) CIK: 0001052284 (see all company filings)

EIN.: 841090791 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-52954 | Film No.: 12976077
SIC: 2834 Pharmaceutical Preparations